Muhammad Mazree Bin Mohamed Mahidin is having an experience of more than a decade in the pharmaceutical sector both as a Regulator and a Corporate Professional. He was with National Pharmaceutical Regulatory Agency (NPRA), Malaysia (formerly known National Pharmaceutical Control Bureau, Malaysia) for a number of years and was involved in GMP inspections (based on PIC/S requirements) covering important aspects such as Quality Management including Risk Management, validations & qualifications, facilities & utilities, production, self-inspections, warehouse management, and documentation. Mr. Mahidin was part of more than 120 pharmaceutical manufacturing inspections across Malaysia.

Mr. Mahidin is a senior consultant at DRK Pharma Solutions and has been providing GxP consultancy to leading companies in South East Asia (including Malaysia & Singapore) for the last many years. He is also a WHO (Geneva) certified consultant for providing GMP consultancies to pharmaceutical companies aspiring for the WHO Prequalification of their products. He also held leadership roles at Idaman Pharma Manufacturing and Ranbaxy Malaysia (a Sun Pharma Company) where he was responsible for qualifications, validations, aseptic process simulations, components & equipment level impact assessment for multi-dose facilities including Sterile Aseptic Manufacturing. His last position was at Sunward Pharmaceutical (Malaysia & Singapore) as the Plant Head.